Chemotherapy-Induced Febrile Neutropenia

Known as: Neutropenias, Chemotherapy-Induced Febrile, Drug-Induced Febrile Neutropenias, Febrile Neutropenia, Drug-Induced 
FEVER accompanied by a significant reduction in NEUTROPHIL count associated with CHEMOTHERAPY.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
BACKGROUND Afatinib, an irreversible ErbB-family blocker, has shown preclinical activity when tested in EGFR mutant models with… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Olaparib is a novel, orally active poly(ADP-ribose) polymerase (PARP) inhibitor that induces synthetic lethality in… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Hodgkin's lymphoma and anaplastic large-cell lymphoma are the two most common tumors expressing CD30. Previous… (More)
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2009
Review
2009
Ovarian cancer is the leading cause of death from gynaecological malignancies in the Western world. Despite the evolution of… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE To determine the antitumor activity of the novel proteasome inhibitor bortezomib in patients with indolent and mantle… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) confer a strong… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE Erlotinib is a highly specific epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor. This phase II… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Modern intensive chemotherapy regimens have improved the prognosis for patients with adult acute lymphocytic leukemia… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
BACKGROUND A study conducted in 1983 to identify and rank the symptoms experienced by patients receiving cancer chemotherapy… (More)
  • table 1
  • table 2
  • table 5
  • figure 1
  • table 6
Is this relevant?
Highly Cited
1993
Highly Cited
1993
BACKGROUND Although many patients with intermediate-grade or high-grade (aggressive) non-Hodgkin's lymphoma are cured by… (More)
Is this relevant?